Lacticaseibacillus rhamnosusFinding
Lacticaseibacillus rhamnosus has no detected effect on aspartate aminotransferase
no difference foundModerate evidenceFinding
01 · The sentence it was drawn from
“ALT and AST decreased within the Del-Immune V® Extra group at month 3 (ALT: −5.88 U/L, 95% CI: −10.27 to −1.49; p = 0.011; AST: −2.78 U/L, 95% CI: −4.74 to −0.81; p = 0.007), but the between-group interaction tests were not significant (ALT p = 0.340; AST p = 0.111).”
Lacticaseibacillus rhamnosus
Aspartate aminotransferase
no difference found
- Who
- Adults aged 18-70 with MASLD (BMI 25-39.9, FLI >60); standard lifestyle-modification programme and counselling in both arms; between-group time-by-treatment interaction over 6 months
- Dose studied
- 100 mg twice daily for 12 weeks, then 3 months follow-up without treatment
Moderate evidencePMID 42942425 · 2026
02 · The study
- Study
- RCT
- Duration
- 3 months
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Medicina (Kaunas, Lithuania)04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7G6G97ZA130VV5666S1FPFT